Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.
View Top Employees from Immunexpress Inc.Website | http://immunexpress.com |
Revenue | $6 million |
Employees | 17 (17 on RocketReach) |
Founded | 2006 |
Address | 425 Pontius Ave N Suite 430, Seattle, Washington 98109, US |
Phone | (206) 858-6436 |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology Research, Business Services, Biotechnology, Medical devices, Science and Engineering, Molecular diagnostics, Genetics, Sepsis, Health Care, Health Diagnostics, Pharmaceutical |
Web Rank | 12 Million |
SIC | SIC Code 807 Companies, SIC Code 80 Companies, SIC Code 8071 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 54 Companies, NAICS Code 6215 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 621 Companies, NAICS Code 541711 Companies, NAICS Code 62151 Companies |
Looking for a particular Immunexpress Inc. employee's phone or email?
The Immunexpress Inc. annual revenue was $6 million in 2024.
Roy Davis is the Chief Medical Officer of Immunexpress Inc..
17 people are employed at Immunexpress Inc..
Immunexpress Inc. is based in Seattle, Washington.
The NAICS codes for Immunexpress Inc. are [62, 54, 6215, 541, 5417, 54171, 621, 541711, 62151].
The SIC codes for Immunexpress Inc. are [807, 80, 8071].